The Black Diamond Therapeutics brand, founded in 2017 (United States), from 2214 competing brands. The Black Diamond Therapeutics brand is owned by BLACK DIAMOND THERAPEUTICS, INC., a company listed in New York. Black Diamond Therapeutics is part of the Biotechnology activity sector.